Kim R Tsuchimoto - Net Worth and Insider Trading
Kim R Tsuchimoto Net Worth
The estimated net worth of Kim R Tsuchimoto is at least $6,260 dollars as of 2024-11-08. Kim R Tsuchimoto is the CFO of Raptor Pharmaceutical Corp and owns about 582 shares of Raptor Pharmaceutical Corp (RPTP) stock worth over $5,238. Kim R Tsuchimoto is also the CFO of Monopar Therapeutics Inc and owns about 65 shares of Monopar Therapeutics Inc (MNPR) stock worth over $1,022. Details can be seen in Kim R Tsuchimoto's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kim R Tsuchimoto has not made any transactions after 2019-12-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kim R Tsuchimoto
Kim R Tsuchimoto Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kim R Tsuchimoto owns 3 companies in total, including Monopar Therapeutics Inc (MNPR) , Raptor Pharmaceutical Corp (RPTP) , and Spatialight Inc (SPLT) .
Click here to see the complete history of Kim R Tsuchimoto’s form 4 insider trades.
Insider Ownership Summary of Kim R Tsuchimoto
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNPR | Monopar Therapeutics Inc | 2022-12-31 | Chief Financial Officer |
| RPTP | Raptor Pharmaceutical Corp | 2012-09-25 | other: Vice President Finance |
| SPLT | Spatialight Inc | 2005-08-01 | Prin Financial & Acctg Officer |
Kim R Tsuchimoto Latest Holdings Summary
Kim R Tsuchimoto currently owns a total of 2 stocks. Among these stocks, Kim R Tsuchimoto owns 582 shares of Raptor Pharmaceutical Corp (RPTP) as of August 29, 2012, with a value of $5,238 and a weighting of 83.67%. Kim R Tsuchimoto also owns 65 shares of Monopar Therapeutics Inc (MNPR) as of December 18, 2019, with a value of $1,022 and a weighting of 16.33%.
Latest Holdings of Kim R Tsuchimoto
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPTP | Raptor Pharmaceutical Corp | 2012-08-29 | 582 | 9.00 | 5,238 |
| MNPR | Monopar Therapeutics Inc | 2019-12-18 | 65 | 15.73 | 1,022 |
Holding Weightings of Kim R Tsuchimoto
Kim R Tsuchimoto Form 4 Trading Tracker
According to the SEC Form 4 filings, Kim R Tsuchimoto has made a total of 0 transactions in Raptor Pharmaceutical Corp (RPTP) over the past 5 years. The most-recent trade in Raptor Pharmaceutical Corp is the sale of 3,510 shares on August 29, 2012, which brought Kim R Tsuchimoto around $17,550.
According to the SEC Form 4 filings, Kim R Tsuchimoto has made a total of 1 transactions in Monopar Therapeutics Inc (MNPR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Monopar Therapeutics Inc is the acquisition of 65 shares on December 18, 2019, which cost Kim R Tsuchimoto around $2,600.
Insider Trading History of Kim R Tsuchimoto
- 1
Kim R Tsuchimoto Trading Performance
Kim R Tsuchimoto Ownership Network
Ownership Network List of Kim R Tsuchimoto
Ownership Network Relation of Kim R Tsuchimoto
Kim R Tsuchimoto Owned Company Details
What does Monopar Therapeutics Inc do?
Who are the key executives at Monopar Therapeutics Inc?
Kim R Tsuchimoto is the Chief Financial Officer of Monopar Therapeutics Inc. Other key executives at Monopar Therapeutics Inc include Chief Operating Officer Andrew Cittadine , director & Chief Executive Officer Chandler Robinson , and other: Acting Chief Medical Officer Patrice Rioux .
Monopar Therapeutics Inc (MNPR) Insider Trades Summary
Over the past 18 months, Kim R Tsuchimoto made no insider transaction in Monopar Therapeutics Inc (MNPR). Other recent insider transactions involving Monopar Therapeutics Inc (MNPR) include a net purchase of 128,508 shares made by Andrew Cittadine , and a net purchase of 1,550 shares made by Karthik Radhakrishnan .
In summary, during the past 3 months, insiders sold 0 shares of Monopar Therapeutics Inc (MNPR) in total and bought 1,550 shares, with a net purchase of 1,550 shares. During the past 18 months, 0 shares of Monopar Therapeutics Inc (MNPR) were sold and 27,252 shares were bought by its insiders, resulting in a net purchase of 27,252 shares.
Monopar Therapeutics Inc (MNPR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Monopar Therapeutics Inc Insider Transactions
Kim R Tsuchimoto Mailing Address
Above is the net worth, insider trading, and ownership report for Kim R Tsuchimoto. You might contact Kim R Tsuchimoto via mailing address: C/o Monopar Therapeutics Inc., 1000 Skokie Blvd., Suite 350, Wilmette Il 60091.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
